JP2019536015A - 良性腫瘍ではなく悪性腫瘍を標的とし、かつ結合する検出可能な分子 - Google Patents
良性腫瘍ではなく悪性腫瘍を標的とし、かつ結合する検出可能な分子 Download PDFInfo
- Publication number
- JP2019536015A JP2019536015A JP2019523046A JP2019523046A JP2019536015A JP 2019536015 A JP2019536015 A JP 2019536015A JP 2019523046 A JP2019523046 A JP 2019523046A JP 2019523046 A JP2019523046 A JP 2019523046A JP 2019536015 A JP2019536015 A JP 2019536015A
- Authority
- JP
- Japan
- Prior art keywords
- target
- tumors
- bind
- benign
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7023—(Hyper)proliferation
- G01N2800/7028—Cancer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Pathology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Optics & Photonics (AREA)
- Biophysics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662412948P | 2016-10-26 | 2016-10-26 | |
| US62/412,948 | 2016-10-26 | ||
| PCT/US2017/058276 WO2018081262A1 (en) | 2016-10-26 | 2017-10-25 | Detectable molecules that target and bind to malignant tumors and not benign tumors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019536015A true JP2019536015A (ja) | 2019-12-12 |
| JP2019536015A5 JP2019536015A5 (enExample) | 2020-10-08 |
Family
ID=62025452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019523046A Pending JP2019536015A (ja) | 2016-10-26 | 2017-10-25 | 良性腫瘍ではなく悪性腫瘍を標的とし、かつ結合する検出可能な分子 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20190255195A1 (enExample) |
| JP (1) | JP2019536015A (enExample) |
| CN (1) | CN109982721A (enExample) |
| WO (1) | WO2018081262A1 (enExample) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040047804A1 (en) * | 1998-10-29 | 2004-03-11 | The General Hospital Corporation, A Massachusetts Corporation | Enhanced radiation therapy |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9678059B2 (en) * | 2010-05-23 | 2017-06-13 | Technion Research & Development Foundation Ltd. | Detection, staging and grading of benign and malignant tumors |
| CN102372771A (zh) * | 2010-08-26 | 2012-03-14 | 杨静雯 | 一种肿瘤靶向分子及其应用 |
| US10106778B2 (en) * | 2012-11-08 | 2018-10-23 | Whitehead Institute For Biomedical Research | Selective targeting of cancer stem cells |
| CN104892820B (zh) * | 2015-05-11 | 2017-08-04 | 厦门大学 | 一种受体类分子靶向显像剂及其制备方法 |
-
2017
- 2017-10-25 US US16/345,073 patent/US20190255195A1/en not_active Abandoned
- 2017-10-25 CN CN201780071462.4A patent/CN109982721A/zh active Pending
- 2017-10-25 JP JP2019523046A patent/JP2019536015A/ja active Pending
- 2017-10-25 WO PCT/US2017/058276 patent/WO2018081262A1/en not_active Ceased
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040047804A1 (en) * | 1998-10-29 | 2004-03-11 | The General Hospital Corporation, A Massachusetts Corporation | Enhanced radiation therapy |
Non-Patent Citations (1)
| Title |
|---|
| JARED J BARROTT: "Optical and radioiodinated tethered Hsp90 inhibitors reveal selective internalization of ectopic Hsp", CHEM BIOL, vol. 20, no. 9, JPN6021029746, 19 September 2013 (2013-09-19), pages 1187 - 1197, XP093019223, ISSN: 0004721789, DOI: 10.1016/j.chembiol.2013.08.004 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN109982721A (zh) | 2019-07-05 |
| US20190255195A1 (en) | 2019-08-22 |
| WO2018081262A1 (en) | 2018-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| D'amato et al. | Update on the biology and therapy of gastrointestinal stromal tumors | |
| Zhang et al. | PET/CT in the diagnosis and prognosis of osteosarcoma | |
| Logrono et al. | Recent Advances in Cell Biology, Diagnosis and Therapy of Gastrointestinal Stroma Tumor (GIST) | |
| Georgescu et al. | Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma | |
| JP2017121233A5 (enExample) | ||
| JP2019144254A (ja) | Psma上昇により致死性前立腺癌が同定される | |
| Bruggink et al. | Current role of imaging in diagnosing aortic graft infections | |
| Campennì et al. | Association of parathyroid carcinoma and thyroid disorders: A clinical review | |
| Sweet et al. | Infiltrative renal malignancies: imaging features, prognostic implications, and mimics | |
| EP3291839A1 (en) | Anti-nucleolin agent-conjugated nanoparticles as radio-sensitizers and mri and/or x-ray contrast agents | |
| Nyström et al. | A genetically encoded magnetic resonance imaging reporter enables sensitive detection and tracking of spontaneous metastases in deep tissues | |
| WO2013166153A2 (en) | Methods and compositions for cancer diagnosis | |
| JP2019536015A (ja) | 良性腫瘍ではなく悪性腫瘍を標的とし、かつ結合する検出可能な分子 | |
| Ferguson | Advances in the adjuvant treatment of infantile fibrosarcoma | |
| Rosa et al. | Colorectal cancer patients before resection of hepatic metastases | |
| Hou et al. | Evaluation of galactography for nipple discharge | |
| Koide et al. | Exfoliated cancer cells during intersphincteric resection for very low rectal cancer | |
| Han et al. | Imaging techniques for minimally invasive thoracic surgery—Korea University Guro Hospital experiences | |
| Shim et al. | Use of laparoscopy as an alternative to computed tomography (CT) and positron emission tomography (PET) scans for the detection of recurrence in patients with gastric cancer: a pilot study | |
| Nakajo et al. | Clinical significance of primary lesion FDG uptake for choice between oesophagectomy and endoscopic submucosal dissection for resectable oesophageal squamous cell carcinomas | |
| Marcheix et al. | Lung metastases of diffuse giant cell tumour of the fibular tendon sheath at the ankle: a case report | |
| Lazarioti et al. | Diagnostic and Therapeutic Efficacy of Imaging Modalities in Non-Small Cell Lung Cancer (NSCLC): experience from a Phase III clinical study using tumor targeted Lipoplatin nanoparticles | |
| Chen | Hodgkin lymphoma | |
| Yan et al. | Aggressive Primary Pericardial Mesothelioma: A Case Report and Review of the Literature | |
| Wang et al. | Surgical Guidance of Head and Neck Squamous Cell Carcinoma Enabled by a c-MET-Targeting Fluorescent Probe cMBP-ICG |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200828 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200828 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20210730 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210803 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20220308 |